Galmed Pharmaceuticals Ltd. (GLMD) Financials
GLMD Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 17.6 million | 2.1 million |
2023-06-30 | 13.3 million | 2.7 million |
2023-03-31 | 14.8 million | 2.8 million |
2022-12-31 | 16.6 million | 3.1 million |
GLMD Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -2.2 million | 226000 |
2023-06-30 | -1.4 million | 174000 |
2023-03-31 | -1.7 million | 297000 |
2022-12-31 | -4.0 million | 182000 |
GLMD Net Income
No data available :(
GLMD Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 13.3 million | - | - |
2023-06-30 | 9.3 million | - | - |
2023-03-31 | 12.2 million | - | - |
2022-12-31 | 13.8 million | - | 44000 |
GLMD Shares Outstanding
GLMD Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | - | 556000 | 912000 | - |
2023-06-30 | - | 809000 | 1.1 million | - |
2023-03-31 | - | 1.1 million | 919000 | - |
2022-12-31 | 1000 | 1.4 million | 1.1 million | - |
GLMD Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | - | - |
2023-06-30 | - | - |
2023-03-31 | - | 8000 |
2022-12-31 | - | 9000 |
GLMD
Price: $0.39
52 week price:
Earnings Per Share: -3.02 USD
P/E Ratio: -0.13
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 176487
Ebitda: -2.7 millionMarket Capitalization: 1.3 million